Practice Improvement Module Menu

Review modules in your focus area:

Practice Improvement Modules capture data related to the care and management of diagnoses, conditions, and surgical procedures. For your selected module(s), you will supply general information about the patient population and patient history as well as information related to the processes of care and outcomes. 

You may select from 28 available modules listed according to practice focus area below. To assist you in your selection, descriptions and downloadable samples for each module are provided. You are encouraged to choose the module(s) that most closely reflects your practice.

Depending on the module, minimum improvement timeframes range from 30 to 395 days. The minimum improvement timeframe is the time period during which you are expected to implement your improvement plan before re-measuring patient data and assessing the impact of your efforts. It is recommended that you carefully read the module descriptions and timeframe requirements before committing to a particular module.

If your practice focus falls outside the areas listed here, consider developing a Self-Directed Quality Improvement Project to create an activity suited to your goals. 


Cataract & Anterior Segment

MODULE

DESCRIPTION

DAYS REQUIRED

Cataract (Surgical Management)

A patient over the age of 40 for whom you have performed cataract surgery and have examined between 20–90 days after surgery. Please complete a PIM for only one eye per patient.

50

YAG Laser Capsulotomy 

A patient over the age of 40 with a posterior chamber intraocular lens for whom you have performed YAG-laser capsulotomy and examined within 90 days postoperatively.

30

COMPREHENSIVE

MODULE

DESCRIPTION

DAYS REQUIRED

Dry Eye Syndrome

Patients with dry eye syndromes or ocular surface diseases due to neurotrophic keratopathy, abnormality of lid position, or abnormality of lid function seen for initial evaluation, and re-examined at least once within the next 12 months. For patients with bilateral disease, include data for both eyes but perform chart abstraction only once.

120

CORNEA & EXTERNAL DISEASE

MODULE

DESCRIPTION

DAYS REQUIRED

Corneal Edema

Patients followed for at least 6 months after corneal transplantation for Corneal Edema.

395

Corneal Ulcer/Bacterial (Infectious) Keratitis

Patients treated and followed for Non-Viral Infectious Keratitis

395

GLAUCOMA

MODULE

DESCRIPTION

DAYS REQUIRED

Primary Open Angle Glaucoma

Patients 18 years and older in whom you have diagnosed unilateral or bilateral primary open-angle glaucoma (POAG) and followed for at least 12 months.  Eligible patients must have had their initial and most recent visual fields performed with the same test pattern and algorithm, and that test pattern and algorithm must provide a Mean Deviation or Mean Defect value.

Patients diagnosed with pseudoexfoliation, pigmentary dispersion, uveitis, or other secondary forms of open-angle glaucoma in EITHER eye are NOT eligible for inclusion.

For patients with bilateral disease, please enter data for the eye with less glaucoma damage unless that eye has the poorer acuity.

120

Primary Angle Closure Glaucoma

Patients age 18 and older who have a diagnosis of “angle closure glaucoma.”  Because of inconsistency and non-standardization of terms within the ophthalmology community, include ANY of the following: 1) those with narrow angles suspected of having angle closure without glaucoma; 2) those suspected of angle closure glaucoma; 3) those with definite angle closure glaucoma. This encompasses all PRIMARY forms of angle closure. It does NOT include secondary forms, such as uveitic glaucoma, neovascular glaucoma, or other causes of synechial angle closure.

120

Primary Open Angle Glaucoma Suspect

Patients 18 years and older whom you have diagnosed as POAG Suspects and followed for at least 12 months. Suspicion of glaucoma can be on the basis of any one or more of the following:  1) elevated IOP; 2) optic nerve status; or 3) visual field status.  Eligible patients must have had their initial and most recent visual fields performed with the same test pattern and algorithm, and that test pattern and algorithm must provide a Mean Deviation or Mean Defect value.

Patients diagnosed with pseudoexfoliation, pigmentary dispersion, uveitis, or other conditions that might be associated with a secondary form of glaucoma in EITHER eye are NOT eligible for inclusion.

For patients with bilateral disease, please enter data for the eye with less suspicion of glaucoma damage unless that eye has the poorer acuity.

120

NEURO-OPHTHALMOLOGY

MODULE

DESCRIPTION

DAYS REQUIRED

Optic Neuritis

Patients age 18 or older you have diagnosed with unilateral optic neuritis of less than 2 weeks duration.

120

Sixth Nerve Palsy

Patients 18 years or older you have diagnosed with unilateral 6th nerve palsy of less than 3 months duration. This PIM takes into consideration that many neuro-ophthalmologists only do initial consultations.

120

OCULOPLASTICS

MODULE

DESCRIPTION

DAYS REQUIRED

Eyelid Malignancy

Patients with an eyelid malignancy who have undergone treatment and have either been followed for a minimum of 90 days or have been released from your care.

120

Blepharoptosis

A patient 18 years or older with acquired blepharoptosis, operated on by you and either followed for 90 days or released from your care.  If bilateral surgery was performed, please choose the RIGHT eye.

120

Thyroid Ophthalmopathy

Patients diagnosed with thyroid orbitopathy on whom you have advised medical or surgical treatment and have followed for at least 6 months (including treatment with topical, systemic, radiation or surgical treatments).

212

OPHTHALMIC PATHOLOGY & ONCOLOGY

MODULE

DESCRIPTION

DAYS REQUIRED

Retinoblastoma

Patients  diagnosed and treated with globe sparing therapy for heritable retinoblastoma and that you have followed for 5 years.

395

Choroidal Melanoma

Patient diagnosed with choroidal melanoma and treated with radiation. The patient must have been followed for a minimum of 5 years following radiation treatment.

395

Pathology-Biopsies for temporal arteritis

Patients for whom biopsies for temporal arteritis performed

120

Pathology-Special Stains

Patients for whom biopsies including special stain were performed 

120

Pathology-Globes

Patient globes with the final diagnosis of retinoblastoma

120

Pathology-Routine Biopsies

Patients for whom routine biopsy performed

120

PEDIATRIC OPHTHALMOLOGY

MODULE

DESCRIPTION

DAYS REQUIRED

Amblyopia

Patients between 3-11 years old for whom you have diagnosed monocular amblyopia with an initial acuity of 20/40 or worse, initiated therapy (non-surgical), and have followed for at least 6 months with optotype recognition acuity for all exams.

180

Esotropia

Patients diagnosed with non-accommodative or partially accommodative esotropia on whom you have performed surgery and have followed for a least 6 months.

270

REFRACTIVE MANAGEMENT

MODULE

DESCRIPTION

DAYS REQUIRED

Lasik for Myopia

Patients over the age of 18 years for whom you have a) diagnosed with MYOPIA b) performed LASIK SURGERY in both eyes, and c) followed for at least 90 days.

120

Toric IOL

Patients over the age of 18 years for whom you have a) performed cataract surgery and b) placed a toric intraocular lens and c) followed for at least 90 days.

120

RETINA & VITREOUS

MODULE

DESCRIPTION

DAYS REQUIRED

Diabetic Retinopathy

Patients 18 years or older with diabetic retinopathy (NPDR or PDR that is not high risk) and clinically significant macular edema involving the center of the macula, seen and treated by you in the past 5 years and subsequently followed by you for at least 12 months.

395

Central Retinal Vein Occlusion (CRVO)

New patients who presented with perfused CRVO and macular edema, seen by you within the past 5 years and followed for at least one year.

395

Exudative AMD

Patients 50 years or older who present with active* exudative subfoveal Age-Related Macular Degeneration seen by you and followed for at least 6 months. Active Exudative is defined by presence of blood, hard exudate or serous fluid.

180

UVEITIS

MODULE

DESCRIPTION

DAYS REQUIRED

Cataract Surgery & Uveitis

Patients with Uveitis who undergo cataract surgery and are followed for at least 6 months post operatively.

212

Recurrent Acute Anterior Uveitis

Patients with at least one prior episode and 6 months follow-up. (Suggest also that last episode resolved in 3 months or less to avoid confusion with Chronic Uveitis.)

212